How Often We Need Injection In Case of AMD and Diabetic Retinography?

Aims to #End Blindness in Pakistan 

The frequency of injections for Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) varies based on the specific treatment regimen and the patient's response to the therapy. Here’s an overview:

Age-related Macular Degeneration (AMD)

- *Initial Treatment Phase*: Typically, patients receive monthly injections of anti-VEGF (vascular endothelial growth factor) drugs, such as ranibizumab (Lucentis) or aflibercept (Eylea), for the first three months.

- *Maintenance Phase*: After the initial phase, the frequency may be reduced to every 4-12 weeks depending on the patient's response. Some regimens follow a "treat and extend" approach, where the interval between injections is gradually increased as long as the condition remains stable.

Diabetic Retinopathy (DR)

- *Proliferative Diabetic Retinopathy (PDR)*: For patients with PDR, anti-VEGF injections may initially be given monthly. Laser therapy is also a common treatment.

- *Diabetic Macular Edema (DME)*: Patients with DME may receive monthly anti-VEGF injections initially. Depending on the response, the frequency may be reduced to every 6-8 weeks or longer.

In both conditions, the specific frequency of injections is determined by the treating ophthalmologist based on the severity of the disease, response to treatment, and individual patient factors. Regular monitoring through follow-up exams and imaging is essential to adjust the treatment plan as needed.

#EndBlindness